RE:RE:RE:RE:Humble and Fred April8 2021I've been invested in ate for years and and agree that one has to have patience with junior biotechs.However,my expectations was that we would see a bit more upward share price by now.Meeting timelines and transparency are the two categories that I look for when determining what action to take with juniors.I am somewhat disappointed with ate in achieving these markers.But,the science is compelling enough to keep holding for now.